Financial Statements · Financial Reporting
Asper Biogene OÜ
Official identifier 14265334Record date 31 Dec 2022
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2022
- Period start
- 1 Jan 2022
- Submitted date
- 26 Jun 2023
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 594,688 |
| Balance sheet | Cash and cash equivalents | 41,565 |
| Balance sheet | Current assets | 234,590 |
| Balance sheet | Current liabilities | 241,220 |
| Balance sheet | Equity | 332,190 |
| Balance sheet | Share capital at nominal value | 2,500 |
| Balance sheet | Non-current assets | 360,098 |
| Balance sheet | Non-current liabilities | 21,278 |
| Balance sheet | Retained earnings (loss) from previous periods | 173,629 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -47,952 |
| Income statement scheme 1 | Labour costs | -257,392 |
| Income statement scheme 1 | Revenue | 782,438 |
| Income statement scheme 1 | Annual period profit / loss | 155,811 |
| Income statement scheme 1 | Operating profit (loss) | 188,080 |
| Income statement scheme 1 | Profit (loss) before income tax | 155,811 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 173,629 |
| Note: Labour costs | Employees | 9 |
| Note: Labour costs | Labour costs | 181,994 |
Linked company
Company: Asper Biogene OÜ